The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection (2025-26)
Product name
OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection
Sponsor name
Maxx Pharma Pty Ltd
Year Range
2025-26